Skip to main content
Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

Fig. 2

The radiological tumor evolution. a computed tomography (CT) scan at baseline showing hepatic metastases of the lung adenocarcinoma. b CT scan shows a partial response after 8 cycles of immunotherapy. c pulmonary progression on the CT scan at 4 months after the discontinuation of immunotherapy. d CT scan image showing a partial response after 8 cycles of immunotherapy rechallenge

Back to article page